0.8075
price up icon2.37%   0.0187
after-market Dopo l'orario di chiusura: .83 0.0225 +2.79%
loading
Precedente Chiudi:
$0.7888
Aprire:
$0.773
Volume 24 ore:
796.21K
Relative Volume:
0.65
Capitalizzazione di mercato:
$86.14M
Reddito:
$45.44M
Utile/perdita netta:
$-35.43M
Rapporto P/E:
-2.375
EPS:
-0.34
Flusso di cassa netto:
$-25.39M
1 W Prestazione:
+5.23%
1M Prestazione:
+10.59%
6M Prestazione:
-45.44%
1 anno Prestazione:
-76.73%
Intervallo 1D:
Value
$0.7496
$0.8131
Intervallo di 1 settimana:
Value
$0.7403
$0.875
Portata 52W:
Value
$0.6434
$3.33

Maxcyte Inc Stock (MXCT) Company Profile

Name
Nome
Maxcyte Inc
Name
Telefono
301-517-5556
Name
Indirizzo
9713 KEY WEST AVENUE,, ROCKVILLE
Name
Dipendente
114
Name
Cinguettio
Name
Prossima data di guadagno
2026-03-24
Name
Ultimi documenti SEC
Name
MXCT's Discussions on Twitter

Compare MXCT vs ABT, SYK, MDT, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
MXCT
Maxcyte Inc
0.8075 84.14M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
110.25 192.10B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
345.78 137.25B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
88.97 115.41B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
69.63 103.81B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
85.09 49.82B 6.07B 1.06B 1.34B 1.8063

Maxcyte Inc Stock (MXCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-11 Downgrade BTIG Research Buy → Neutral
2025-08-07 Downgrade William Blair Outperform → Mkt Perform
2025-07-22 Iniziato Stephens Overweight
2023-11-29 Iniziato Craig Hallum Buy
2021-10-15 Ripresa Cowen Outperform
2021-08-24 Iniziato BTIG Research Buy
2021-08-24 Iniziato Cowen Outperform
2021-08-24 Iniziato Stephens Overweight
2021-08-24 Iniziato Stifel Buy
2021-08-24 Iniziato Wedbush Outperform
2021-08-24 Iniziato William Blair Outperform
Mostra tutto

Maxcyte Inc Borsa (MXCT) Ultime notizie

pulisher
Mar 09, 2026

MaxCyte unveils new 96-well electroporation platform to accelerate discovery - SelectScience

Mar 09, 2026
pulisher
Mar 07, 2026

MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

Why MaxCyte Inc. stock attracts high net worth investorsBuy Signal & Intraday High Probability Setup Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

Options Flow: Can MaxCyte Inc sustain its profitabilityJuly 2025 Fed Impact & Safe Capital Growth Stock Tips - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 02, 2026

MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Update - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Free cash flow per share of MaxCyte, Inc. – FWB:MYE0 - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Analysts - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

MaxCyte, Inc.Common Stock (NQ: MXCT - The Chronicle-Journal

Mar 01, 2026
pulisher
Feb 25, 2026

MaxCyte unveils ExPERT DTx, a 96-well electroporation platform to accelerate discovery - marketscreener.com

Feb 25, 2026
pulisher
Feb 25, 2026

MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

Insider Buy: Is MaxCyte Inc trading at a discountJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 24, 2026

MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - The Manila Times

Feb 24, 2026
pulisher
Feb 24, 2026

New MaxCyte lab device runs 96 cell samples in a three-minute cycle - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - The Manila Times

Feb 24, 2026
pulisher
Feb 23, 2026

MXCT | MaxCyte, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative

Feb 23, 2026
pulisher
Feb 23, 2026

MaxCyte, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - Quiver Quantitative

Feb 23, 2026
pulisher
Feb 23, 2026

MaxCyte schedules March 24 call on 2025 results for 4:30 p.m. ET - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

MXCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 23, 2026
pulisher
Feb 20, 2026

Market Leaders: What is BEDUs book value per shareWeekly Volume Report & Long-Term Growth Stock Strategies - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Take Profit: Is MaxCyte Inc a momentum stockJuly 2025 PostEarnings & Capital Protection Trading Alerts - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

What are MaxCyte Inc.’s recent SEC filings showingMarket Activity Recap & Daily Profit Focused Stock Screening - mfd.ru

Feb 20, 2026
pulisher
Feb 18, 2026

Dividend Watch: Is MaxCyte Inc forming a breakout patternWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 18, 2026

Day Trade: Will MaxCyte Inc benefit from rising consumer demand2025 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 17, 2026

Cadian Capital discloses 3.5% MaxCyte (MXCT) stake in latest 13G/A - Stock Titan

Feb 17, 2026
pulisher
Feb 14, 2026

MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January - MarketBeat

Feb 14, 2026
pulisher
Feb 14, 2026

Is MaxCyte Inc. being accumulated by smart money2025 Institutional Moves & Daily Market Momentum Tracking - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Will MaxCyte Inc. stock outperform Nasdaq indexJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Is MaxCyte Inc. stock gaining market shareTreasury Yields & Short-Term High Return Ideas - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Capricorn Fund Managers Ltd Acquires 8,200,000 Shares in MaxCyte Inc - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Is MaxCyte Inc. stock a value trapJuly 2025 Review & Real-Time Stock Movement Alerts - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

Will MaxCyte Inc. benefit from rising consumer demandBond Market & Community Trade Idea Sharing - mfd.ru

Feb 11, 2026
pulisher
Feb 08, 2026

Brokerages Set MaxCyte, Inc. (NASDAQ:MXCT) PT at $7.00 - Defense World

Feb 08, 2026
pulisher
Feb 07, 2026

MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen - MarketBeat

Feb 07, 2026
pulisher
Feb 05, 2026

Capricorn Fund takes 7.7% stake in MaxCyte (NASDAQ: MXCT) - Stock Titan

Feb 05, 2026
pulisher
Feb 03, 2026

MaxCyte (NASDAQ:MXCT) Stock Price Down 4.2%Here's Why - MarketBeat

Feb 03, 2026
pulisher
Feb 01, 2026

Sentiment Recap: Can ATGL grow without dilutionQuarterly Growth Report & Technical Entry and Exit Tips - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 30, 2026

MaxCyte team building boosts morale at sales meeting - Traders Union

Jan 30, 2026
pulisher
Jan 29, 2026

Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 28, 2026

IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 27, 2026

Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru

Jan 27, 2026
pulisher
Jan 20, 2026

Hedge Fund Bets: Is Algoma Steel Group Inc benefiting from interest rate changesMarket Performance Recap & High Return Stock Watch Alerts - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 19, 2026

Rally Mode: Is MaxCyte Inc showing insider buyingTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 17, 2026

Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 15, 2026

Portfolio Shifts: What is the next catalyst for MaxCyte IncFed Meeting & Breakout Confirmation Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 13, 2026

Investor Mood: How interest rate cuts could boost MaxCyte Inc stockQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

MaxCyte to join the 2026 G-Rex Grant Tour in Houston - Traders Union

Jan 13, 2026
pulisher
Jan 13, 2026

Published on: 2026-01-14 11:01:42 - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Day Trade: Is MaxCyte Inc stock affected by interest rate hikesOil Prices & Safe Entry Momentum Stock Tips - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail

Jan 12, 2026
pulisher
Jan 12, 2026

MaxCyte announces preliminary unaudited fourth quarter and full year 2025 financial results - marketscreener.com

Jan 12, 2026

Maxcyte Inc Azioni (MXCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$93.73
price up icon 2.21%
medical_devices STE
$221.55
price down icon 0.24%
$66.31
price down icon 2.18%
medical_devices PHG
$28.81
price down icon 0.48%
$72.65
price down icon 0.11%
medical_devices EW
$85.09
price down icon 0.80%
Capitalizzazione:     |  Volume (24 ore):